delete The Health Service Medicines (Control of Prices and Supply of Information) (Amendment) Regulations 2015
Amends the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007 and the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008. Creates exemptions from sales reporting for manufacturers/suppliers in voluntary schemes, mandates 6-year record-keeping of transaction data (sales income and quantities), introduces Secretary of State powers to requisition information with 28-day response deadlines, and extends price control exemptions for framework agreement procurements.
This regulation imposes heavy administrative burdens through mandatory 6-year transaction record-keeping and 28-day information response requirements, creating compliance costs ultimately passed to the NHS and patients. It strengthens government price controls on branded medicines, distorting pharmaceutical market signals and potentially reducing supply and innovation incentives. The exemption system for 'voluntary scheme' members effectively mandates participation in government-controlled schemes, reducing market flexibility. These information requisition powers amount to bureaucratic surveillance of commercial transactions without clear evidence the compliance costs produce corresponding benefits outweighing their burden.